glp 1 medication for pcos What You Must Know About Taking GLP-1s if you Have GLP-1 for PCOS: Is It

Data from commercial health insurance (not workers compensation) includes that in 2024, about 34% of employers provided coverage for GLP-1 drugs for both diabetes and weight loss, up from 26% in 2023 (Employers Covering GLP-q Drugs in Health Plans Could Nearly Double in 2024, 2023)

In the coming weeks, Novo Nordisk is expected to release fresh Phase III data for its next-generation weight loss treatment CagriSema, which analysts say could be the next big thing in the obesity space

doi: 10.1016/j.chest.2016.06.030 252 YamadaS.SeyamaS.WajimaT.YuzawaY.SaitoM.TanakaE.et al

I need a hype, man

Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions

it also may stimulate the formation of new neuronal connections and the formation of new neurons from stem cells